(Circulation. 2001;104:429.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Medicine, Harbor-UCLA Medical Center, Torrance, Calif.
Correspondence to Karlman Wasserman, MD, PhD, Department of Medicine, Harbor-UCLA Medical Center, 1000 W Carson St, Box 405, Torrance, CA 90509-2910. E-mail kwasserm{at}ucla.edu
Background Patients with primary pulmonary hypertension (PPH) have a pulmonary vasculopathy that leads to exercise intolerance due to dyspnea and fatigue. To better understand the basis of the exercise limitation in patients with PPH, cardiopulmonary exercise testing (CPET) with gas exchange measurements, New York Heart Association (NYHA) symptom class, and resting pulmonary hemodynamics were studied.
Methods and Results We retrospectively evaluated 53 PPH patients who had right heart catheterization and cycle ergometer CPET studies to maximum tolerance as part of their clinical workups. No adverse events occurred during CPET. Reductions in peak O2 uptake (
O2), anaerobic threshold, peak O2 pulse, rate of increase in
O2, and ventilatory efficiency were consistently found. NYHA class correlated well with the above parameters of aerobic function and ventilatory efficiency but less well with resting pulmonary hemodynamics.
Conclusions Patients with PPH can safely undergo noninvasive cycle ergometer CPET to their maximal tolerance. The CPET abnormalities were consistent and characteristic and correlated well with NYHA class.
Key Words: oxygen hypertension, pulmonary ventilation exercise hemodynamics
This article has been cited by other articles:
![]() |
S. Provencher, P. Herve, O. Sitbon, M. Humbert, G. Simonneau, and D. Chemla Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension Eur. Respir. J., August 1, 2008; 32(2): 393 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Heart, March 1, 2008; 94(Suppl_1): i1 - i41. [Full Text] [PDF] |
||||
![]() |
National Pulmonary Hypertension Centres of the UK Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41. [Full Text] [PDF] |
||||
![]() |
R. Naeije and S. Huez Right ventricular function in pulmonary hypertension: physiological concepts Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H5 - H9. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Lang Management of acute and chronic RV dysfunction Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H61 - H67. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hoeper, M. W. Pletz, H. Golpon, and T. Welte Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension Eur. Respir. J., May 1, 2007; 29(5): 944 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Alkotob, P. Soltani, M. A. Sheatt, M. C. Katsetos, N. Rothfield, W. D. Hager, R. J. Foley, and D. I. Silverman Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest, July 1, 2006; 130(1): 176 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dimopoulos, D. O. Okonko, G.-P. Diller, C. S. Broberg, T. V. Salukhe, S. V. Babu-Narayan, W. Li, A. Uebing, S. Bayne, R. Wensel, et al. Abnormal Ventilatory Response to Exercise in Adults With Congenital Heart Disease Relates to Cyanosis and Predicts Survival Circulation, June 20, 2006; 113(24): 2796 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Holverda, C. T.-J. Gan, J. T. Marcus, P. E. Postmus, A. Boonstra, and A. Vonk-Noordegraaf Impaired Stroke Volume Response to Exercise in Pulmonary Arterial Hypertension J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1732 - 1733. [Full Text] [PDF] |
||||
![]() |
S. Provencher, D. Chemla, P. Herve, O. Sitbon, M. Humbert, and G. Simonneau Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension Eur. Respir. J., January 1, 2006; 27(1): 114 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Deboeck, G. Niset, J-L. Vachiery, J-J. Moraine, and R. Naeije Physiological response to the six-minute walk test in pulmonary arterial hypertension Eur. Respir. J., October 1, 2005; 26(4): 667 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chaouat, A.-S. Bugnet, N. Kadaoui, R. Schott, I. Enache, A. Ducolone, M. Ehrhart, R. Kessler, and E. Weitzenblum Severe Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 189 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yasunobu, R. J. Oudiz, X.-G. Sun, J. E. Hansen, and K. Wasserman End-tidal PCO2 Abnormality and Exercise Limitation in Patients With Primary Pulmonary Hypertension Chest, May 1, 2005; 127(5): 1637 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Naeije Breathing more with weaker respiratory muscles in pulmonary arterial hypertension Eur. Respir. J., January 1, 2005; 25(1): 6 - 8. [Full Text] [PDF] |
||||
![]() |
F. J. Meyer, D. Lossnitzer, A. V. Kristen, A. M. Schoene, W. Kubler, H. A. Katus, and M. M. Borst Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension Eur. Respir. J., January 1, 2005; 25(1): 125 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hansen, X.-G. Sun, Y. Yasunobu, R. P. Garafano, G. Gates, R. J. Barst, and K. Wasserman Reproducibility of Cardiopulmonary Exercise Measurements in Patients With Pulmonary Arterial Hypertension Chest, September 1, 2004; 126(3): 816 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Leuchte, C. Neurohr, R. Baumgartner, M. Holzapfel, W. Giehrl, M. Vogeser, and J. Behr Brain Natriuretic Peptide and Exercise Capacity in Lung Fibrosis and Pulmonary Hypertension Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 360 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Rubin and R. Naeije Sildenafil for Enhanced Performance at High Altitude? Ann Intern Med, August 3, 2004; 141(3): 233 - 235. [Full Text] [PDF] |
||||
![]() |
M. McGoon, D. Gutterman, V. Steen, R. Barst, D. C. McCrory, T. A. Fortin, and J. E. Loyd Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 14S - 34S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Barst, M. McGoon, A. Torbicki, O. Sitbon, M. J. Krowka, H. Olschewski, and S. Gaine Diagnosis and differential assessment of pulmonary arterial hypertension J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 40S - 47S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Hoeper, R. J. Oudiz, A. Peacock, V. F. Tapson, S. G. Haworth, A. E. Frost, and A. Torbicki End points and clinical trial designs in pulmonary arterial hypertension: Clinical and regulatory perspectives J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 48S - 55S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Peacock, R. Naeije, N. Galie, and J.T. Reeves End points in pulmonary arterial hypertension: the way forward Eur. Respir. J., June 1, 2004; 23(6): 947 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Deboeck, G. Niset, M. Lamotte, J-L. Vachiery, and R. Naeije Exercise testing in pulmonary arterial hypertension and in chronic heart failure Eur. Respir. J., May 1, 2004; 23(5): 747 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Leuchte, M. Holzapfel, R. A. Baumgartner, I. Ding, C. Neurohr, M. Vogeser, T. Kolbe, M. Schwaiblmair, and J. Behr Clinical significance of brain natriuretic peptide in primary pulmonary hypertension J. Am. Coll. Cardiol., March 3, 2004; 43(5): 764 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W Mikhail, S. K Prasad, W. Li, P. Rogers, A. H Chester, S. Bayne, D. Stephens, M. Khan, J.S.R Gibbs, T. W Evans, et al. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects Eur. Heart J., March 1, 2004; 25(5): 431 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Glaser, C. F. Opitz, U. Bauer, R. Wensel, R. Ewert, P. E. Lange, and F. X. Kleber Assessment of Symptoms and Exercise Capacity in Cyanotic Patients With Congenital Heart Disease Chest, February 1, 2004; 125(2): 368 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.M. Hoeper, N. Taha, A. Bekjarova, R. Gatzke, and E. Spiekerkoetter Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids Eur. Respir. J., August 1, 2003; 22(2): 330 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-G. Sun, J. E. Hansen, R. J. Oudiz, and K. Wasserman Pulmonary function in primary pulmonary hypertension J. Am. Coll. Cardiol., March 19, 2003; 41(6): 1028 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF] |
||||
![]() |
X.-G. Sun, J. E. Hansen, N. Garatachea, T. W. Storer, and K. Wasserman Ventilatory Efficiency during Exercise in Healthy Subjects Am. J. Respir. Crit. Care Med., December 1, 2002; 166(11): 1443 - 1448. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chemla, V. Castelain, P. Herve, Y. Lecarpentier, and S. Brimioulle Haemodynamic evaluation of pulmonary hypertension Eur. Respir. J., November 1, 2002; 20(5): 1314 - 1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Nagaya, Y Shimizu, T Satoh, H Oya, M Uematsu, S Kyotani, F Sakamaki, N Sato, N Nakanishi, and K Miyatake Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension Heart, April 1, 2002; 87(4): 340 - 345. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-G. Sun, J. E. Hansen, R. J. Oudiz, and K. Wasserman Gas Exchange Detection of Exercise-Induced Right-to-Left Shunt in Patients With Primary Pulmonary Hypertension Circulation, January 1, 2002; 105(1): 54 - 60. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |